These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29651287)

  • 1. Neutralizing Anti-Cytokine Autoantibodies Against Interferon-α in Immunodysregulation Polyendocrinopathy Enteropathy X-Linked.
    Rosenberg JM; Maccari ME; Barzaghi F; Allenspach EJ; Pignata C; Weber G; Torgerson TR; Utz PJ; Bacchetta R
    Front Immunol; 2018; 9():544. PubMed ID: 29651287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.
    Uzel G; Sampaio EP; Lawrence MG; Hsu AP; Hackett M; Dorsey MJ; Noel RJ; Verbsky JW; Freeman AF; Janssen E; Bonilla FA; Pechacek J; Chandrasekaran P; Browne SK; Agharahimi A; Gharib AM; Mannurita SC; Yim JJ; Gambineri E; Torgerson T; Tran DQ; Milner JD; Holland SM
    J Allergy Clin Immunol; 2013 Jun; 131(6):1611-23. PubMed ID: 23534974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein microarrays identify disease-specific anti-cytokine autoantibody profiles in the landscape of immunodeficiency.
    Rosenberg JM; Price JV; Barcenas-Morales G; Ceron-Gutierrez L; Davies S; Kumararatne DS; Döffinger R; Utz PJ
    J Allergy Clin Immunol; 2016 Jan; 137(1):204-213.e3. PubMed ID: 26365387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.
    Meisel C; Akbil B; Meyer T; Lankes E; Corman VM; Staudacher O; Unterwalder N; Kölsch U; Drosten C; Mall MA; Kallinich T; Schnabel D; Goffinet C; von Bernuth H
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34061776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome.
    De Benedetti F; Insalaco A; Diamanti A; Cortis E; Muratori F; Lamioni A; Carsetti R; Cusano R; De Vito R; Perroni L; Gambarara M; Castro M; Bottazzo GF; Ugazio AG
    Clin Gastroenterol Hepatol; 2006 May; 4(5):653-9. PubMed ID: 16630773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
    Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1.
    Breivik L; Oftedal BE; Bøe Wolff AS; Bratland E; Orlova EM; Husebye ES
    Clin Immunol; 2014 Jul; 153(1):220-7. PubMed ID: 24792136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects.
    Muramatsu K; Ujiie H; Kobayashi I; Nishie W; Izumi K; Ito T; Yoshimoto N; Natsuga K; Iwata H; Shimizu H
    J Allergy Clin Immunol; 2018 Dec; 142(6):1818-1830.e6. PubMed ID: 29704593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Difference in target antigens between central tolerance and peripheral tolerance deficiencies].
    Chida N; Kobayashi I
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(3):142-9. PubMed ID: 26213192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From autoimmune enteropathy to the IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) syndrome.
    Blanco Quirós A; Arranz Sanz E; Bernardo Ordiz D; Garrote Adrados JA
    Allergol Immunopathol (Madr); 2009; 37(4):208-15. PubMed ID: 19912978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
    Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
    J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease specificity of anti-tryptophan hydroxylase-1 and anti-AIE-75 autoantibodies in APECED and IPEX syndrome.
    Chida N; Kobayashi I; Takezaki S; Ueki M; Yamazaki Y; Garelli S; Scarpa R; Horikawa R; Yamada M; Betterle C; Notarangelo LD; Yawaka Y; Ariga T
    Clin Immunol; 2015 Jan; 156(1):36-42. PubMed ID: 25463430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characteristics of immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China.
    An YF; Xu F; Wang M; Zhang ZY; Zhao XD
    Scand J Immunol; 2011 Sep; 74(3):304-309. PubMed ID: 21595732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.
    Passerini L; Di Nunzio S; Gregori S; Gambineri E; Cecconi M; Seidel MG; Cazzola G; Perroni L; Tommasini A; Vignola S; Guidi L; Roncarolo MG; Bacchetta R
    Eur J Immunol; 2011 Apr; 41(4):1120-31. PubMed ID: 21400500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA.
    Charbonnier LM; Janssen E; Chou J; Ohsumi TK; Keles S; Hsu JT; Massaad MJ; Garcia-Lloret M; Hanna-Wakim R; Dbaibo G; Alangari AA; Alsultan A; Al-Zahrani D; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2015 Jan; 135(1):217-27. PubMed ID: 25468195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IPEX as a result of mutations in FOXP3.
    van der Vliet HJ; Nieuwenhuis EE
    Clin Dev Immunol; 2007; 2007():89017. PubMed ID: 18317533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodeficiencies with autoimmune consequences.
    Notarangelo LD; Gambineri E; Badolato R
    Adv Immunol; 2006; 89():321-70. PubMed ID: 16682278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.
    d'Hennezel E; Bin Dhuban K; Torgerson T; Piccirillo CA
    J Med Genet; 2012 May; 49(5):291-302. PubMed ID: 22581967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digestive histopathological presentation of IPEX syndrome.
    Patey-Mariaud de Serre N; Canioni D; Ganousse S; Rieux-Laucat F; Goulet O; Ruemmele F; Brousse N
    Mod Pathol; 2009 Jan; 22(1):95-102. PubMed ID: 18820676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.